Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Servier Ventures is the corporate venture capital arm of Servier, a global independent pharmaceutical group governed by a non-profit foundation. The firm invests in early-stage life science companies that align with Servier's strategic focus areas, including oncology, neuroscience, and immuno-inflammation. By providing capital and expertise, Servier Ventures aims to accelerate the development of innovative therapies and foster long-term partnerships within the biotech ecosystem. The fund typically targets Seed to Series B rounds, supporting startups from discovery through clinical proof-of-concept.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Servier Ventures.